Quick10K

⚲

Plyzer Technologies

Filings

10-Q	2019-12-31	Filed 2020-04-06
10-Q	2019-09-30	Filed 2019-11-18
10-Q	2019-06-30	Filed 2019-09-12
10-K	2019-03-31	Filed 2019-08-02
10-Q	2018-12-31	Filed 2019-02-14
10-Q	2018-09-30	Filed 2018-11-19
10-Q	2018-06-30	Filed 2018-08-21
10-K	2018-03-31	Filed 2018-07-12
10-Q	2017-12-31	Filed 2018-02-16
10-Q	2017-09-30	Filed 2017-11-20
10-Q	2017-06-30	Filed 2017-08-21
10-K	2017-03-31	Filed 2017-06-29
10-Q	2016-12-31	Filed 2017-02-08
10-Q	2016-09-30	Filed 2016-11-03
10-Q	2016-06-30	Filed 2016-08-15
10-K	2016-03-31	Filed 2016-06-28
10-Q	2015-12-31	Filed 2016-02-04
10-Q	2015-09-30	Filed 2015-11-13
10-Q	2015-06-30	Filed 2015-08-12
10-K	2015-03-31	Filed 2015-07-16
10-Q	2014-12-31	Filed 2015-02-17
10-Q	2014-09-30	Filed 2014-11-17
10-Q	2014-06-30	Filed 2014-08-15
10-K	2014-03-31	Filed 2014-06-30
10-Q	2014-02-18	Filed 2014-02-18
10-Q	2013-08-14	Filed 2013-08-14
10-K	2013-03-31	Filed 2013-07-09
10-Q	2013-02-19	Filed 2013-02-19
10-Q	2012-11-21	Filed 2012-11-21
10-Q	2012-08-03	Filed 2012-08-13
10-K	2012-03-31	Filed 2012-06-22
10-Q	2011-12-31	Filed 2012-02-14
10-Q	2011-09-30	Filed 2011-11-07
10-Q	2011-06-30	Filed 2011-08-05
10-K	2011-03-31	Filed 2011-06-27
10-Q	2010-12-31	Filed 2011-02-15
10-Q	2010-09-30	Filed 2010-11-15
10-Q	2010-06-30	Filed 2010-08-16
10-K	2010-03-31	Filed 2010-07-14
10-Q	2009-12-31	Filed 2010-02-16

Reports

8-K	2020-11-13
8-K	2020-08-11
8-K	2020-06-17
8-K	2020-01-07
8-K	2019-06-20
8-K	2018-10-24
8-K	2018-09-26
8-K	2018-01-26

Plyzer Technologies Financials

PLYZ Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546,418	322,654	0	0	0	0	-853,740
1 800 Flowers Com (FLWS)	944,324	42%	13.3	6%	664,955	335,559	1,266,390	533,727	36,761	75,090	1,000,932
10x Genomics (TXG)	4,804,979	75%	-490.3	-2%	572,815	151,367	61,207	45,727	-9,603	-8,887	4,357,180
12 Retech (RETC)	0	32%	-0.1	-1,385%	1,118	20,421	625	199	-15,491	-14,800	966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	33,711	0%	0.4	-5%	164,088	108,405	18,194	0	-7,969	-8,017	-2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	18,527	23,194	27,219	6,699	-2,862	-1,433	3,396
1895 Bancorp of Wisconsin (BCOW)	46,152,715		12,508.1	-0%	441,187	382,722	0	0	-44	3,689	46,142,359
1st Constitution Bancorp (FCCY)	164,504	0%	4.4	1%	1,342,565	1,204,038	490	0	13,787	32,503	143,748
1st Franklin Financial (FFC)	3,551		-0.6	7%	905,107	644,730	0	0	62,078	80,004	-45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200,033		7.9	1%	6,691,070	5,858,028	0	0	70,061	136,342	1,072,548
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	1,849	0	0	-1,663	-1,654	250
21Vianet Group (VNET)	6,005,116			0%	11,150,717	5,787,533	0	0	0	0	3,344,095
22nd Century (XXII)	301,854	1%	-14.1	-36%	61,864	6,554	25,706	304	-22,433	-21,464	301,826
1Life Healthcare (ONEM)


Balance Sheet ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-11-21	2013-02-19	2013-03-31	2013-08-14	2013-09-30	2014-02-18	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	1	0	0	8	2	4	5	3	2	74	5	3	47	21	27	17	12	8	8	1	1	0	40	184	103	262	39	207	218	183	262	189
Accounts Receivable																															37	7
Inventory
PP&E																							4	3	4	5	5	4	3	3	66	75
Assets	1	1	0	441	487	506	507	505	505	577	569	619	657	116	113	101	13	9	8	1	1	17	107	442	110	283	58	261	234	207	654	606
Accounts Payable
Long-Term Debt	10							325	325	325	325	325	325
Liabilities	151	153	40	444	507	528	539	546	544	574	642	776	895	453	462	449	452	123	113	82	87	160	386	567	500	1,399	1,558	1,869	1,514	2,730	5,166	3,704
Stockholders' Equity	-150	-152	-40	-3	-20	-22	-32	-40	-39	3	-74	-157	-238	-337	-349	-348	-439	-114	-104	-81	-87	-143	-278	-125	-390	-1,116	-1,501	-1,607	-1,280


Income Statement ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-11-21	2013-02-19	2013-03-31	2013-08-14	2013-09-30	2014-02-18	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	34	3
Cost of Revenue
Gross Profit
R&D
SG&A	0	2	1	4	4	4	1	2	2	1	7	10	23	22	5	3	2	2	2	1	1	5	11	9	11	17	12	21	13	38	248	151
Tax															0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0
Net Income	2	-3	112	-22	-15	-9	-13	-3	-5	-65	-66	-85	-91	-2,088	-55	-31	-136	-499	-18	26	-10	-69	-136	-144	-480	-1,050	-387	-20,946	-1,516	-2,577	-3,116	-2,191


Cash Flow ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-11-21	2013-02-19	2013-03-31	2013-08-14	2013-09-30	2014-02-18	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		-2	116		-3	1	-27	-10	-6	-24	-71	-113	14	-65	-26	-8	-7	-2	-1	-4	-8	-71	-155	-239	-125	-395	-349	-424		-780	-594	-1,155
Cash Investing					-52	-17	0	0	0	0	-48	-2	-47	10	-2								-4	0	-1	-2					-155	-10
Cash Financing		2	-116		-276	19	24	13	-0	89	61	111	66	8	35	-5	0	0				71	199	380	46	562	125	591		744	829	1,094